Close Menu

NEW YORK (GenomeWeb) – Promega Biotech India, a subsidiary of Promega Corporation, and Gurgaon, India-based laboratory Core Diagnostics have entered into a collaboration to make available Promega's microsatellite instability test to guide the use of cancer immunotherapies.

Financial terms of the deal were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.